No link between type I interferon autoantibody positivity and adverse reactions to COVID-19 vaccines
Abstract Type I interferons act as gatekeepers against viral infection, and autoantibodies that neutralize these signaling molecules have been associated with COVID-19 severity and adverse reactions to the live-attenuated yellow fever vaccine. On this background, we sought to examine whether autoant...
Full description
Bibliographic Details
Main Authors: |
Ahmet Yalcinkaya,
Marco Cavalli,
Axel Cederholm,
Maribel Aranda-Guillén,
Anish Behere,
Hedvig Mildner,
Tadepally Lakshmikanth,
Laura Gonzalez,
Constantin Habimana Mugabo,
Anette Johnsson,
Olov Ekwall,
Olle Kämpe,
Sophie Bensing,
Petter Brodin,
Pär Hallberg,
Mia Wadelius,
Nils Landegren |
Format: | Article
|
Language: | English |
Published: |
Nature Portfolio
2024-02-01
|
Series: | npj Vaccines
|
Online Access: | https://doi.org/10.1038/s41541-024-00829-9
|